[Pyr3]-Beta-Amyloid-Protein (3-42)
[Pyr3]-Beta-Amyloid-Protein (3-42) was found to be the predominant amyloid ?-peptide structure deposited in human brain of Alzheimer's disease and Down's syndrome patients. Therefore, [Pyr3]-Beta-Amyloid-Protein (3-42) is suggested to accumulate in the brain and to trigger the formation of insoluble amyloid ?-peptide deposits. Nussbaum et al. studies the Prion-like behaviour and tau-dependent cytotoxicity of the truncated A? sequence.
| Catalog No. | 5991534 |
| Product Category | Peptide |
| Sequence | Pyr-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
| CAS No. | 183449-57-2 |
| Mol. Formula | C196H299N53O55S |
| Mol. Weight | 4309.97 |
| Purity | > 95% |
| MOQ | 1 mg |
| Storage/Stability | -20°C/1 year |
| Shipping | Gel Packs |